1Pavlidis N,Fizazi K.Cancer of unknown primary(CUP)[].Critical Reviews in Oncology Hematology.2005
2Le ChevalIer T,Cvitkovic E,Callle P,et al.EarIy metastaticcancer of unknown primary origin at presentation.A clinicalstudy of 302 consecutive autopsied patients[].Arch lnternMed.1988
3Pentheroudakis G,Briasoulis E,Karavasilis V,et al.Chem-otherapy for patients with two favourabIe subsets of un-known primary carcinoma:Aclive,but how effeclive?[].Acta Oncologica.2005
4HedIey DW,Leary JA,Kirsten F.Metastatic adenocarcino-ma of unknown primary site:Abnormalities of cellular DNAcontent and survival[].European Journal of Cancer and Clinical Oncology.1985
5Abbruzzese JL,Lenzi R,Raber MN,et al.The biology of un-known primary tumors[].Seminars in Oncology.1993
6Motzer RJ,Rodriguez E,Reuter VE,et al.Genetic analysisas an aid in diagnosis for patients with midIine carcinomasof uncertaln histologies[].Journal of the National Cancer Institute.1991
7PavIidis N,Briasoulis E,Bai M,et al.Overexpression of C-myc,Ras and C-erbB-2 onco-proteins in carcinoma of un-known primary origin[].Anticancer Research.1995
8Van de Wouw AJ,Jansen RL,Speel EJ,et al.The unknownbiology of the unknown pnmary tumour,A Iiterature review[].Annals of Oncology.2003
9Dova L,Georgiou L,rVartholomatos G,et al.EGFR and C-KIT/CD117 gene mutational screening and oncoprotein ex-pression in patients with cancer of unknown primary:Impli-cations for molecular pathophysiology and therapy[].European Journal of Cancer.2005
10Fizazi K,Voigt JJ,Lesimple T,et al.Carcinoma of un-known primary(CUP):Are the tyrosine kinase receptorsHER-2,EGF-R,and c-Kit suitable targets for therapy?[].ProcAm Soc Clin Oncol.2003
